GSK-3-mediated phosphorylation enhances Maf-transforming activity
Nathalie Rocques1, Nancy Abou Zeid, Karine Sii-Felice
1Institut Curie, Centre de Recherche, Orsay F-91405, France.
Abstract:
The Maf oncoproteins are b-Zip transcription factors of the AP-1 superfamily. They are involved in developmental, metabolic, and tumorigenic processes. Maf proteins are overexpressed in about 50% of human multiple myelomas. Here, we show that Maf-transforming activity is controlled by GSK-3-dependent phosphorylation and that phosphorylation by GSK-3 can increase the oncogenic activity of a protein. Using microarray analysis, we identify a gene-expression subprogram regulated by GSK-3-mediated Maf phosphorylation involved in extracellular matrix remodeling and relevant to cancer progression. We also demonstrate that GSK-3 triggers MafA sequential phosphorylation on residues S61, T57, T53, and S49, inducing its ubiquitination and degradation. Paradoxically, this phosphorylation increases MafA-transcriptional activity through the recruitment of the coactivator P/CAF. We further demonstrate that P/CAF protects MafA from ubiquitination and degradation, suggesting that, upon the release of the coactivator complex, MafA becomes polyubiquitinated and degraded to allow the response to terminate.
Insights
Glycogen synthase kinase-3 (GSK-3) phosphorylation of Maf oncoproteins enhances their oncogenic activity. This process involves MafA ubiquitination and degradation, paradoxically increasing its transcriptional activity.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Maf oncoproteins, AP-1 superfamily members, regulate development, metabolism, and tumorigenesis.
- Maf proteins are overexpressed in multiple myeloma, indicating their role in cancer progression.
Purpose of the Study:
- To investigate the role of GSK-3 dependent phosphorylation in controlling Maf oncoprotein activity.
- To identify downstream targets and mechanisms regulated by GSK-3 mediated Maf phosphorylation.
Main Methods:
- Microarray analysis to identify gene expression changes.
- Phosphorylation site mapping and analysis of ubiquitination and degradation pathways.
- Co-immunoprecipitation to study protein interactions.
Main Results:
- GSK-3 dependent phosphorylation increases Maf oncoprotein's oncogenic activity.
- GSK-3 mediated Maf phosphorylation regulates a gene-expression subprogram involved in extracellular matrix remodeling.
- GSK-3 triggers sequential phosphorylation of MafA, leading to ubiquitination and degradation.
- Phosphorylation paradoxically enhances MafA transcriptional activity by recruiting the coactivator P/CAF, which protects MafA from degradation.
Conclusions:
- GSK-3 plays a critical role in regulating Maf oncoprotein activity and oncogenic potential.
- The interplay between GSK-3, MafA, and P/CAF influences cancer progression through extracellular matrix remodeling.
- Understanding this regulatory mechanism offers potential therapeutic targets for multiple myeloma and other cancers.
Related Concept Videos
MAPK Signaling Cascades
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...


